A detailed history of Hunter Associates Investment Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Hunter Associates Investment Management LLC holds 21,790 shares of NVO stock, worth $1.85 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
21,790
Previous 21,790 -0.0%
Holding current value
$1.85 Million
Previous $3.11 Million 16.61%
% of portfolio
0.4%
Previous 0.52%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$122.71 - $146.91 $503,847 - $603,212
-4,106 Reduced 15.86%
21,790 $3.11 Million
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $16,337 - $21,747
160 Added 0.62%
25,896 $3.33 Million
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $1.18 Million - $2.59 Million
12,999 Added 102.06%
25,736 $2.34 Million
Q2 2022

Aug 10, 2022

BUY
$103.24 - $121.81 $76,087 - $89,773
737 Added 6.14%
12,737 $1.42 Million
Q2 2021

Aug 05, 2021

SELL
$67.66 - $84.76 $48,241 - $60,433
-713 Reduced 5.61%
12,000 $1.01 Million
Q1 2021

May 10, 2021

BUY
$67.06 - $75.82 $26,824 - $30,327
400 Added 3.25%
12,713 $857,000
Q4 2020

Jan 29, 2021

BUY
$63.89 - $73.8 $77,498 - $89,519
1,213 Added 10.93%
12,313 $860,000
Q4 2019

Feb 07, 2020

SELL
$49.86 - $58.26 $14,958 - $17,478
-300 Reduced 2.63%
11,100 $642,000
Q3 2018

Nov 09, 2018

SELL
$46.76 - $51.24 $29,225 - $32,025
-625 Reduced 5.2%
11,400 $537,000
Q2 2018

Aug 10, 2018

SELL
$44.29 - $50.42 $5,536 - $6,302
-125 Reduced 1.03%
12,025 $555,000
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $499,972 - $598,023
12,150
12,150 $585,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hunter Associates Investment Management LLC Portfolio

Follow Hunter Associates Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Associates Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Associates Investment Management LLC with notifications on news.